Constulose (Actavis Inc.)
Welcome to the PulseAid listing for the Constulose drug offered from Actavis Inc.. This Osmotic Laxative [EPC],Osmotic Activity [MoA],Acidifying Activity [MoA],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Actavis Inc. |
NON-PROPRIETARY NAME: | Lactulose |
SUBSTANCE NAME: | LACTULOSE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Osmotic Laxative [EPC],Osmotic Activity [MoA],Acidifying Activity [MoA],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE] |
ROUTE: | ORAL |
DOSAGE FORM: | SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2011-02-28 |
END MARKETING DATE: | 0000-00-00 |
Constulose HUMAN PRESCRIPTION DRUG Details:
Item Description | Constulose from Actavis Inc. |
LABELER NAME: | Actavis Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 10(g/15mL) |
START MARKETING DATE: | 2011-02-28 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 45963-439_16ed7f67-42ec-4e5e-bfc4-8e7e31eb9c50 |
PRODUCT NDC: | 45963-439 |
APPLICATION NUMBER: | ANDA090503 |
Other LACTULOSE Pharmaceutical Manufacturers / Labelers: